Home
About Us
What is PCEDM?
History
Mission and Vision
Constitution and By-Laws
Organizational Structure
Officers
Past Presidents
Hymn
International Affiliation
Advocacy
Council
Diabetes Mellitus and Metabolic Syndrome
EndoGreen
Thyroid Diseases
Bone Diseases
Lipid, Obesity and Nutrition
Reproductive disorders and Transgender medicine
Adrenal and Pituitary gland diseases
Research and Publications
Training
Fellowship Training Institutions
University of Santo Tomas
Makati Medical Center
Philippine General Hospital
The Medical City
East Avenue Medical Center
Chinese General Hospital
St. Luke’s Medical Center Quezon City
St. Luke’s Medical Center – Global City
Chong Hua Hospital
De La Salle University Medical Center
Cardinal Santos Medical Center
Southern Philippine Medical Center
Training Curriculum
News & Events
Members
Members Homepage
Training Programs
Research Workshops
Categories
How To Join
Benefits
Members Directory
COVID-19
Gallery
Menu
Home
About Us
What is PCEDM?
History
Mission and Vision
Constitution and By-Laws
Organizational Structure
Officers
Past Presidents
Hymn
International Affiliation
Advocacy
Council
Diabetes Mellitus and Metabolic Syndrome
EndoGreen
Thyroid Diseases
Bone Diseases
Lipid, Obesity and Nutrition
Reproductive disorders and Transgender medicine
Adrenal and Pituitary gland diseases
Research and Publications
Training
Fellowship Training Institutions
University of Santo Tomas
Makati Medical Center
Philippine General Hospital
The Medical City
East Avenue Medical Center
Chinese General Hospital
St. Luke’s Medical Center Quezon City
St. Luke’s Medical Center – Global City
Chong Hua Hospital
De La Salle University Medical Center
Cardinal Santos Medical Center
Southern Philippine Medical Center
Training Curriculum
News & Events
Members
Members Homepage
Training Programs
Research Workshops
Categories
How To Join
Benefits
Members Directory
COVID-19
Gallery
Daily archives: October 28, 2024
Home
Daily archives: October 28, 2024
OCTOBER 28, 2024
0
The New Steatotic Liver Disease Subclassification and the New MASH-targeted Pharmacotherapy: Resmetirom
By Maria Nikki Cruz, MD Steatotic Liver Disease (SLD) has various etiologies (Figure 1). Metabolic dysfunction-associated steatotic liver disease (MASLD),